Autoimmune Encephalitis Clinical Trials

65 clinical trials for Autoimmune Encephalitis across international registries, including 18 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Biomarkers in Autoimmune Disease of Nervous System — RECRUITING
• A multicenter randomized, controlled, double-blinded trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis — RECRUITING
• Cohort Study on Neuroimmune Diseases in the Reproductive Age — RECRUITING
• Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. — RECRUITING · PHASE1
• CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases — RECRUITING · PHASE1
• A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease — RECRUITING · PHASE2
• Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis? — RECRUITING · PHASE2
• FDG-PET in the Diagnosis of Autoimmune Encephalitis — RECRUITING
• Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis — RECRUITING
• Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research — RECRUITING
• Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases — RECRUITING · PHASE1
• Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis — RECRUITING · PHASE2
• A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis — RECRUITING
• Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism — RECRUITING · NA
• The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis — RECRUITING · PHASE2
• Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis) — RECRUITING · NA
• Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System — RECRUITING · PHASE1
• Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes — RECRUITING
• A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune Encephalitis In Children 12 Years or Older and Adults — NOT_YET_RECRUITING · PHASE2
• Relapse and Functional Outcomes in Anti-LGI1 Encephalitis — COMPLETED
• Plasma Exchange in Pediatric Autoimmune Encephalitis — NOT_YET_RECRUITING · NA
• OPM- MEG in Non-immune And iMmune-medIated Neurological Disease — ACTIVE_NOT_RECRUITING · NA
• Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune Cerebellitis — NOT_YET_RECRUITING · PHASE4
• A GLOBAL, MULTICENTER, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF EFGARTIGIMOD PH20 SC IN ADULT AND ADOLESCENT PARTICIPANTS WITH AUTOIMMUNE ENCEPHALITIS — NOT_YET_RECRUITING · PHASE2
• A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis — TERMINATED · PHASE2
• IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2 — ACTIVE_NOT_RECRUITING · PHASE2
• Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants — COMPLETED · PHASE1
• Phase 1 Study of ART5803 in Healthy Participants — COMPLETED · PHASE1
• Tongji NADs Cohort — NOT_YET_RECRUITING
• A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy — NOT_YET_RECRUITING · PHASE1
• Long-term Impact of NMDAR Encephalitis — COMPLETED
• Is [18F]-DPA-714 PET a good marker of neuroinflammation in autoimmune encephalitis? (EAI-714) — TERMINATED · PHASE2
• Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory Syndromes — ACTIVE_NOT_RECRUITING
• hUC-MSC-Exo Therapy for Autoimmune Encephalitis — NOT_YET_RECRUITING · PHASE1
• Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis — COMPLETED · PHASE2
• CPI Combination Therapy for Autoimmune Encephalitis — COMPLETED · NA
• Clinical Characteristics of Patients With Anti-Collapsin Response Mediator Protein 2 Antibodies in Encephalitis or Encephalomyelitis — COMPLETED
• Neuro-ophthalmology and Autoimmune Encephalitis (NODE) — COMPLETED
• A Multicentric Cohort of Autoimmune Encephalitis — NOT_YET_RECRUITING
• Clinical Features and Prognostic Markers in Adult Patients With AE Requiring ICU Treatment — OTHER
• National, Multicentric Registry Study on Neuroimmunological Diseases in China — OTHER
• Metabolic Imaging for Diagnosis and Prognostication of Autoimmune encephalitiS — OTHER
• A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER BASKET STUDY TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SATRALIZUMAB IN PATIENTS WITH ANTI-N-METHYL-DASPARTIC ACID RECEPTOR (NMDAR) OR ANTI-LEUCINE RICH GLIOMA INACTIVATED 1 (LGI1) ENCEPHALITIS. — NOT_YET_RECRUITING · PHASE3
• Validation of a Diagnostic Score for Encephalitis to Assess the Risk of Autoimmune Origin — OTHER
• Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune Encephalitis — OTHER
• Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy — OTHER
• BRIEF TITLE * (in English and Sufficiently Descriptive) Role of MRI in Anti-LGI1 Encephalitis — COMPLETED
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 2 STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF ROZANOLIXIZUMAB IN ADULT STUDY PARTICIPANTS WITH LEUCINE-RICH GLIOMA INACTIVATED 1 AUTOIMMUNE ENCEPHALITIS — NOT_YET_RECRUITING · PHASE2
• Diagnostic Performance of a Commercial Assay for the Detection of Neuronal Antibodies — COMPLETED
• Long-term Follow up of Patient With Anti-GABAbr Antibodies Associated-encephalitis. — COMPLETED

Refine this search